Terms: = Endocrine gland cancer AND FANCA, MGC75158, 2175, ENSG00000187741, FA-H, FA, FAA, FANCH, FA1, FACA AND Treatment
133 results:
1. Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan.
Cheng SM; Su YY; Chiang NJ; Wang CJ; Chao YJ; Huang CJ; Tsai HJ; Chen SH; Chang CY; Tsai CR; Li YJ; Yen CJ; Chuang SC; Chang JS; Shan YS; Hwang DY; Chen LT
J Biomed Sci; 2024 Feb; 31(1):21. PubMed ID: 38350919
[TBL] [Abstract] [Full Text] [Related]
2. Drug resistance mechanisms in dopamine agonist-resistant prolactin pituitary neuroendocrine tumors and exploration for new drugs.
Cheng J; Xie W; Chen Y; Sun Y; Gong L; Wang H; Li C; Zhang Y
Drug Resist Updat; 2024 Mar; 73():101056. PubMed ID: 38277755
[TBL] [Abstract] [Full Text] [Related]
3. Targeting endogenous fatty acid synthesis stimulates the migration of ovarian cancer cells to adipocytes and promotes the transport of fatty acids from adipocytes to cancer cells.
Grunt TW; Wagner R; Ries A; Berghoff AS; Preusser M; Grusch M; Valent P
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38214315
[TBL] [Abstract] [Full Text] [Related]
4. The effect of paclitaxel- and fisetin-loaded PBM nanoparticles on apoptosis and reversal of drug resistance gene ABCG2 in ovarian cancer.
McFadden M; Singh SK; Kinnel B; Varambally S; Singh R
J Ovarian Res; 2023 Nov; 16(1):220. PubMed ID: 37990267
[TBL] [Abstract] [Full Text] [Related]
5. PRMT5 Inhibitors Regulate DNA Damage Repair Pathways in cancer Cells and Improve Response to PARP Inhibition and Chemotherapies.
Carter J; Hulse M; Sivakumar M; Burtell J; Thodima V; Wang M; Agarwal A; Vykuntam K; Spruance J; Bhagwat N; Rager J; Ruggeri B; Scherle P; Ito K
Cancer Res Commun; 2023 Nov; 3(11):2233-2243. PubMed ID: 37861290
[TBL] [Abstract] [Full Text] [Related]
6. FAK inhibitor PF-562271 inhibits the migration and proliferation of high-grade serous ovarian cancer cells through FAK and FAK mediated cell cycle arrest.
Pan Q; Wang Q; Zhao T; Zhao X; Liang Y; Shi M; Chen C; Lin F
Med Oncol; 2023 Jun; 40(8):215. PubMed ID: 37382687
[TBL] [Abstract] [Full Text] [Related]
7. Synergistic antitumor effect of folate-targeted Pluronic™ F-127/poly(lactic acid) polymersomes for codelivery of doxorubicin and paclitaxel.
Wu TY; Li ZL; Gong YC; Xiong XY
Nanomedicine (Lond); 2023 Feb; 18(5):455-469. PubMed ID: 37166001
[TBL] [Abstract] [Full Text] [Related]
8. Disulfiram enhances the antitumor activity of cisplatin by inhibiting the Fanconi anemia repair pathway.
Yuan M; Wu Q; Zhang M; Lai M; Chen W; Yang J; Jiang L; Cao J
J Zhejiang Univ Sci B; 2023 Mar; 24(3):207-220. PubMed ID: 36915997
[TBL] [Abstract] [Full Text] [Related]
9. Germline cancer Gene Expression Quantitative Trait Loci Are Associated with Local and Global Tumor Mutations.
Liu Y; Gusev A; Kraft P
Cancer Res; 2023 Apr; 83(8):1191-1202. PubMed ID: 36745477
[TBL] [Abstract] [Full Text] [Related]
10. Folate receptor-targeted PLGA-PEG nanoparticles for enhancing the activity of genistein in ovarian cancer.
Patra A; Satpathy S; Naik PK; Kazi M; Hussain MD
Artif Cells Nanomed Biotechnol; 2022 Dec; 50(1):228-239. PubMed ID: 36330543
[TBL] [Abstract] [Full Text] [Related]
11. An Acid Response IR780-Based Targeted Nanoparticle for Intraoperative Near-Infrared Fluorescence Imaging of Ovarian cancer.
Song J; Ye H; Jiang S; Yang Y; Li X
Int J Nanomedicine; 2022; 17():4961-4974. PubMed ID: 36275480
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic factors and mitotane treatment of adrenocortical cancer. Two decades of experience from an institutional case series.
Tőke J; Uhlyarik A; Lohinszky J; Stark J; Huszty G; Micsik T; Borka K; Reismann P; Horányi J; Igaz P; Tóth M
Front Endocrinol (Lausanne); 2022; 13():952418. PubMed ID: 36246926
[TBL] [Abstract] [Full Text] [Related]
13. Targeted delivery and anticancer effects of Chrysin-loaded chitosan-folic acid coated solid lipid nanoparticles in pancreatic malignant cells.
Farhadi A; Homayouni Tabrizi M; Sadeghi S; Vala D; Khosravi T
J Biomater Sci Polym Ed; 2023 Feb; 34(3):315-333. PubMed ID: 36063019
[TBL] [Abstract] [Full Text] [Related]
14. Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma.
Gong J; Thomassian S; Kim S; Gresham G; Moshayedi N; Ye JY; Yang JC; Jacobs JP; Lo S; Nissen N; Gaddam S; Tighiouart M; Osipov A; Hendifar A
Sci Rep; 2022 Sep; 12(1):15013. PubMed ID: 36056179
[TBL] [Abstract] [Full Text] [Related]
15. Long-term hormonal and imaging outcomes of adjunctive gamma knife radiosurgery in non-functioning pituitary adenomas: a single center experience.
Maldar AN; Pattankar S; Misra BK; Chauhan PH; Sankhe M; Desai K; Shah NF
J Neurooncol; 2022 Jul; 158(3):423-433. PubMed ID: 35593947
[TBL] [Abstract] [Full Text] [Related]
16. Evaluation of Lipocalin-2 and Twist expression in thyroid cancers and its relationship with epithelial mesenchymal transition.
Celepli P; Bigat İ; Karabulut S; Celepli S; Hücümenoğlu S
Ann Diagn Pathol; 2022 Aug; 59():151973. PubMed ID: 35569209
[TBL] [Abstract] [Full Text] [Related]
17. Safe and efficient 2D molybdenum disulfide platform for cooperative imaging-guided photothermal-selective chemotherapy: A preclinical study.
Li X; Kong L; Hu W; Zhang C; Pich A; Shi X; Wang X; Xing L
J Adv Res; 2022 Mar; 37():255-266. PubMed ID: 35499043
[TBL] [Abstract] [Full Text] [Related]
18. Folic Acid-Modified Fluorescent-Magnetic Nanoparticles for Efficient Isolation and Identification of Circulating Tumor Cells in Ovarian cancer.
Pan Y; Wang Z; Ma J; Zhou T; Wu Z; Ding P; Sun N; Liu L; Pei R; Zhu W
Biosensors (Basel); 2022 Mar; 12(3):. PubMed ID: 35323454
[TBL] [Abstract] [Full Text] [Related]
19. Genome-wide CRISPR/Cas9 library screen identifies PCMT1 as a critical driver of ovarian cancer metastasis.
Zhang J; Li Y; Liu H; Zhang J; Wang J; Xia J; Zhang Y; Yu X; Ma J; Huang M; Wang J; Wang L; Li Q; Cui R; Yang W; Xu Y; Feng W
J Exp Clin Cancer Res; 2022 Jan; 41(1):24. PubMed ID: 35033172
[TBL] [Abstract] [Full Text] [Related]
20. Clinical and Sonographic Features of Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features: A Retrospective Study.
Ni X; Xu S; Zhang B; Zhan W; Zhou W
Ultrasound Q; 2023 Mar; 39(1):23-31. PubMed ID: 35001029
[TBL] [Abstract] [Full Text] [Related]
[Next]
